Table of Contents
- Understanding Your Treatment Options
- What Is IV Ketamine?
- What Is Spravato (Esketamine)?
- Key Differences Between IV Ketamine and Spravato
- Effectiveness Comparison
- Treatment Experience and Administration
- Cost and Insurance Coverage
- Side Effects and Safety Considerations
- Who Is a Good Candidate for Each Treatment
- Making Your Decision
- Frequently Asked Questions
- Next Steps in Your Treatment Journey
Understanding Your Treatment Options
When traditional antidepressants haven’t provided the relief you need, you’re not out of options. Two FDA-cleared ketamine-based treatments offer new hope for treatment-resistant depression: IV ketamine infusions and Spravato (esketamine) nasal spray.
Both treatments work differently than conventional antidepressants. Instead of targeting serotonin or other neurotransmitters, they block NMDA receptors in your brain, potentially creating new neural pathways and providing rapid relief from depression symptoms.
This comparison will help you understand the key differences between IV ketamine and Spravato, so you can make an informed decision about which treatment might be right for your situation.
What Is IV Ketamine?
IV ketamine involves receiving ketamine through an intravenous infusion over 40-60 minutes in a clinical setting. The medication is the same ketamine that’s been used safely in medical settings for decades, but at much lower doses specifically for depression treatment.
During treatment, you’ll sit comfortably in a monitored environment while the medication is slowly administered. Many patients begin to feel relief within hours or days of their first treatment, though a series of treatments is typically needed for sustained improvement.
IV ketamine is considered an “off-label” use of an FDA-approved medication. This means doctors can legally prescribe it based on clinical evidence, even though it wasn’t originally approved specifically for depression.
What Is Spravato (Esketamine)?
Spravato is the brand name for esketamine, a nasal spray that’s FDA-approved specifically for treatment-resistant depression. Esketamine is derived from ketamine but is a more concentrated form of the medication’s active component.
You self-administer Spravato under medical supervision by spraying it into your nostrils. The treatment takes place in a healthcare provider’s office, and you’ll need to remain there for monitoring for at least two hours after each dose.
Unlike IV ketamine, Spravato received FDA approval specifically for treatment-resistant depression in 2019, making it the first new type of depression medication approved in decades.
Key Differences Between IV Ketamine and Spravato
Administration Method
- IV Ketamine: Delivered through an IV line over 40-60 minutes
- Spravato: Self-administered nasal spray that takes just minutes to use
FDA Status
- IV Ketamine: Off-label use of FDA-approved ketamine
- Spravato: FDA-approved specifically for treatment-resistant depression
Chemical Composition
- IV Ketamine: Contains both S-ketamine and R-ketamine molecules
- Spravato: Contains only S-ketamine (esketamine)
Treatment Setting Requirements
- IV Ketamine: Administered in various clinical settings with basic monitoring
- Spravato: Must be given in certified healthcare facilities with specific safety protocols
Insurance Coverage
- IV Ketamine: Typically not covered by insurance
- Spravato: Often covered by insurance plans
Effectiveness Comparison
Both treatments show significant promise for treatment-resistant depression, but their effectiveness profiles differ slightly.
IV Ketamine Effectiveness
Clinical studies suggest that 60-70% of patients with treatment-resistant depression experience meaningful improvement with IV ketamine. Many patients report feeling better within 24-48 hours of their first treatment.
The effects of IV ketamine may last longer between treatments for some patients, potentially allowing for less frequent maintenance sessions once initial improvement is achieved.
Spravato Effectiveness
FDA approval for Spravato was based on clinical trials showing that patients experienced significantly greater improvement compared to those receiving placebo plus standard antidepressants.
In clinical trials, patients using Spravato alongside their existing antidepressant showed meaningful improvement within weeks of starting treatment. The medication appears to work best when combined with continued oral antidepressant therapy.
Response Timeline
Both treatments can provide faster relief than traditional antidepressants, which often take 6-8 weeks to show effects. However, individual response times vary, and some patients may need several treatments before experiencing significant improvement.
Treatment Experience and Administration
IV Ketamine Experience
During IV ketamine treatment, you’ll recline comfortably while the medication is administered through a small IV catheter. Most patients describe the experience as relaxing, though some may experience mild dissociative effects during the infusion.
The treatment environment is typically calm and controlled, with dimmed lighting and comfortable seating. You’ll be monitored throughout the session, and most patients can resume normal activities within a few hours.
Spravato Experience
Spravato treatment begins with you self-administering the nasal spray under medical supervision. The spray may cause temporary nasal discomfort, runny nose, or unusual taste.
After administration, you’ll remain in the treatment facility for at least two hours for monitoring. During this time, you may experience dissociation, dizziness, or sedation, which typically resolves before you’re cleared to leave.
Treatment Frequency
- IV Ketamine: Often starts with 2-3 treatments per week, then transitions to maintenance treatments every 2-6 weeks
- Spravato: Typically administered twice weekly for the first month, then weekly or every other week for maintenance
Cost and Insurance Coverage
IV Ketamine Costs
IV ketamine treatments are typically paid out-of-pocket, as most insurance plans don’t cover off-label ketamine use for depression. Treatment costs can range from $400-800 per session, depending on your location and provider.
Some clinics offer package deals or financing options to make treatment more accessible. CareCredit and other medical financing options may be available to help manage costs.
Spravato Costs
Spravato is more likely to be covered by insurance since it has FDA approval for treatment-resistant depression. However, coverage varies by plan, and you may still face significant co-pays or deductibles.
Without insurance, Spravato can be expensive, with costs potentially reaching $6,000-9,000 per month. The manufacturer offers patient assistance programs that may help reduce costs for eligible patients.
Long-term Cost Considerations
When comparing costs, consider the frequency of treatments needed for maintenance. Some patients find they need fewer IV ketamine maintenance treatments compared to ongoing Spravato sessions, which could affect long-term expenses.
Side Effects and Safety Considerations
Common Side Effects for Both Treatments
Both IV ketamine and Spravato can cause:
- Dissociation or feeling disconnected from reality
- Dizziness or lightheadedness
- Nausea
- Increased blood pressure and heart rate
- Drowsiness
IV Ketamine-Specific Considerations
IV ketamine side effects are typically limited to the treatment period and immediate hours afterward. The controlled IV administration allows for precise dosing and immediate response to any adverse reactions.
Some patients prefer IV administration because they feel more in control of the experience, knowing medical staff can adjust the infusion rate if needed.
Spravato-Specific Considerations
Spravato may cause nasal-related side effects like runny nose, nasal discomfort, or throat irritation due to the nasal spray delivery method.
The FDA requires Spravato to be administered only in certified healthcare facilities due to the risk of sedation and dissociation. You cannot drive for the rest of the day after treatment.
Safety Monitoring
Both treatments require medical supervision and monitoring of vital signs. Patients with certain heart conditions, uncontrolled high blood pressure, or substance abuse history may not be suitable candidates for either treatment.
Who Is a Good Candidate for Each Treatment
IV Ketamine Candidates
IV ketamine may be appropriate if you:
- Have treatment-resistant depression (tried 2+ antidepressants without success)
- Prefer the controlled environment of IV administration
- Want flexibility in treatment scheduling and location
- Are comfortable with off-label medication use
- Can manage out-of-pocket treatment costs
Veterans with service-connected PTSD or depression may find particular benefit from IV ketamine, especially when treated at veteran-founded clinics that understand military-related trauma.
Spravato Candidates
Spravato may be appropriate if you:
- Have treatment-resistant depression with documented failed antidepressant trials
- Prefer insurance coverage for your treatment
- Want FDA-approved medication specifically for your condition
- Are willing to continue taking oral antidepressants alongside Spravato
- Can commit to the required treatment schedule and facility visits
Factors That May Affect Candidacy
Both treatments require careful medical evaluation. Your provider will consider your medical history, current medications, mental health status, and treatment goals when determining the best option.
Patients with certain medical conditions, including uncontrolled cardiovascular disease or active substance use disorders, may not be suitable candidates for either treatment.
Making Your Decision
Choosing between IV ketamine and Spravato depends on your individual circumstances, preferences, and treatment goals. Consider these factors:
Insurance and Financial Considerations
If insurance coverage is important to you, Spravato may be the more accessible option. However, don’t let insurance status alone determine your choice if one treatment seems more suitable for your needs.
Treatment Preferences
Some patients prefer the precision and control of IV administration, while others appreciate the simplicity of a nasal spray. Consider which method feels more comfortable for your situation.
Scheduling Flexibility
IV ketamine may offer more flexibility in treatment locations and scheduling, while Spravato requires visits to certified facilities with specific protocols.
Provider Expertise
Look for providers experienced in both treatments who can offer personalized guidance based on your specific situation. Veteran-founded clinics may offer specialized understanding if you have military-related trauma or PTSD.
Frequently Asked Questions
How quickly do IV ketamine and Spravato work for depression?
Both treatments can provide faster relief than traditional antidepressants. Some patients notice improvement within hours or days, while others may need several treatments. Individual response times vary significantly.
Can I switch from one treatment to the other?
Yes, patients can potentially switch between IV ketamine and Spravato under medical supervision. Your provider can help determine if switching makes sense based on your response and circumstances.
Do I need to stop my current antidepressants?
This depends on the specific treatment and your current medications. Spravato is typically used alongside existing antidepressants, while IV ketamine protocols vary. Always consult your provider before making medication changes.
How long do the effects of each treatment last?
Treatment effects vary by individual. Some patients maintain improvement for weeks between sessions, while others may need more frequent treatments. Both typically require ongoing maintenance treatments.
Are there any long-term risks with either treatment?
Both treatments have been studied for safety, but long-term effects are still being researched. Your provider will monitor you for any potential issues and adjust treatment as needed.
Can veterans get special consideration for these treatments?
Some veteran-founded clinics offer specialized programs and understanding of military-related trauma. Veterans may also have different insurance considerations through VA benefits or military insurance.
What happens if neither treatment works for me?
If one treatment doesn’t provide adequate relief, your provider may suggest trying the other option, adjusting treatment protocols, or exploring additional therapies like psychotherapy or IV vitamin therapy.
Next Steps in Your Treatment Journey
If you’re considering IV ketamine or Spravato for treatment-resistant depression, the first step is consulting with qualified mental health professionals who can evaluate your specific situation.
At Valor Health Solutions, we offer both FDA-cleared Spravato and IV ketamine infusions, along with comprehensive mental health services including psychotherapy, coaching, and IV vitamin therapy. Our veteran-founded practice understands the challenges of treatment-resistant depression and provides personalized care through both in-person visits at our Clearwater, Florida and Johnson City, Tennessee locations, plus secure virtual sessions nationwide.
We believe you shouldn’t have to choose between treatments without proper guidance. Our $49 consultation helps you understand your options without pressure or obligation.
When other treatments haven’t worked, there’s still a path forward. Better mental health starts with taking the first step toward exploring your options.
Learn more at valorhealthconnect.com or call 888-214-2144 to discuss which treatment might be right for your situation.
